Lab-on-chip (LOC) diagnostics — the microfluidic integration of sample preparation, amplification, detection, and readout onto a single chip enabling complex molecular diagnostics at the point of care — represents a major BioMEMS application creating the point-of-care diagnostics transformation, with the BioMEMS Market reflecting lab-on-chip as the highest commercial growth application in BioMEMS diagnostics.

GeneXpert (Cepheid) — the commercial success story of LOC molecular diagnostics achieving over one billion dollars in annual cartridge revenue from the microfluidic PCR and electrode array integration enabling bedside TB, COVID-19, MRSA, and multi-drug resistance testing in developing and developed world settings. GeneXpert's self-contained cartridge integrating sample preparation, nucleic acid extraction, PCR amplification, and fluorescence detection in a single fluidic cartridge demonstrating the commercial scale of successful LOC implementation.

PDMS and polymer microfluidics — the transition from silicon-based LOC fabrication toward polydimethylsiloxane (PDMS), cyclic olefin copolymer (COC), and PMMA polymer microfluidic chips enabling high-volume injection molding manufacturing at dramatically lower per-chip cost than silicon. The polymer microfluidics enabling disposable diagnostic cartridge economics with unit costs under two dollars enabling broad deployment.

Digital microfluidics and electrowetting-on-dielectric (EWOD) — the emerging LOC platform using electrical signals to manipulate discrete droplets on electrode arrays rather than continuous flow channels — creating the next-generation programmable microfluidic platform. The EWOD platform's software-reconfigurability enabling a single hardware platform to run different assay protocols by changing software and reagents rather than different cartridge designs.

Do you think lab-on-chip molecular diagnostics will eventually replace central laboratory PCR for most infectious disease diagnosis, bringing molecular accuracy to the point-of-care at central lab equivalent cost?

FAQ

What is lab-on-chip technology and how does it integrate multiple functions? Lab-on-chip (LOC): miniaturized microfluidic device integrating sample processing steps that conventionally require separate laboratory equipment; functions integrated: sample introduction, filtration/separation, cell lysis, nucleic acid extraction/purification, amplification (PCR, LAMP, NASBA), detection (fluorescence, electrochemical, colorimetric); fabrication: PDMS soft lithography; injection-molded polymers (COC, PMMA); silicon microfabrication; paper microfluidics; advantages: low sample volume, fast analysis, reduced contamination risk, portable, potentially low-cost at volume; limitations: complex manufacturing validation, regulatory approval for IVD, limited throughput for high-volume testing.

What are the leading lab-on-chip diagnostic platforms commercially available? Leading commercial LOC diagnostics: GeneXpert (Cepheid/Danaher) — molecular POC gold standard; Abbott ID NOW — isothermal amplification; bioMérieux FilmArray — respiratory/GI syndromic panels; BD MAX — molecular diagnostics; Roche cobas Liat — molecular POC; Idylla (Biocartis) — oncology molecular; Micronics — microfluidic POC (acquired by Qiagen); emerging: various CRISPR-based LOC diagnostics (Sherlock, Mammoth); collectively representing multi-billion-dollar LOC diagnostics commercial market; COVID-19 pandemic dramatically accelerating LOC molecular diagnostic adoption and investment.

#BioMEMS #LabOnChip #MicrofluidicDiagnostics #GeneXpert #POCdiagnostics #MolecularLOC